Medicenna Therapeutics Corp

NASDAQ:MDNA  
3.41
+0.17 (+5.25%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Medicenna Therapeutics Corp Stock, NASDAQ:MDNA

2 Bloor Street West, 7th floor, Toronto, Ontario M4W 3E2
Phone: +1.416.648.5555
Number of Employees: 7

Description

Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company which engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in Toronto, Canada.